BC
LEGN icon

Bayforest Capital’s Legend Biotech LEGN Stock Holding History

Bayforest Capital’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.8K Buy
+3,528
New +$67.3K 0.07% 501
2025
Q2 		– Sell
-1,227
Closed -$41.6K – 844
2025
Q1 		$41.6K Buy
1,227
+248
+25% +$8.89K 0.02% 580
2024
Q4 		$31.9K Buy
+979
New +$40.6K 0.04% 525

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bayforest Capital's LEGN Position: Q1 2026 in Review

Bayforest Capital opened a new position in Legend Biotech (LEGN) in Q1 2026: 3,528 shares worth $63.8K. The stake represents 0.07% of the portfolio and ranks #501 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in LEGN as recently as Q1 2025.

Bayforest Capital first reported a position in LEGN in Q4 2024 and has held it in 3 quarters since. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Bayforest Capital held 3,528 shares of Legend Biotech worth $63.8K as of Q1 2026.
  • Legend Biotech was a new Bayforest Capital position in Q1 2026.
  • Legend Biotech made up 0.07% of Bayforest Capital's portfolio in Q1 2026, its #501 holding.
  • Bayforest Capital first reported a position in Legend Biotech in Q4 2024 and has held it in 3 quarters since.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.